Deep Dive Into Precision BioSciences Stock: Analyst Perspectives (4 Ratings)
Portfolio Pulse from Benzinga Insights
Precision BioSciences (NASDAQ:DTIL) has received mixed analyst ratings, with 4 analysts providing bullish perspectives. The average 12-month price target has significantly increased to $49.75 from $3.00. Key financial indicators show strong profitability and effective cost management.
May 16, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Precision BioSciences has received 4 bullish analyst ratings, with a significant increase in the average 12-month price target to $49.75. The company's financial indicators show strong profitability and effective cost management.
The bullish analyst ratings and significant increase in the average 12-month price target suggest positive market sentiment. Strong financial indicators such as high net margin, ROE, and ROA further support a positive outlook for the stock.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100